Observational analysis highlights biomarker-driven strategies in metastatic colorectal cancer, suggesting improved treatment efficacy.
Introduction Metastatic colorectal cancer (mCRC) remains a leading cause of cancer mortality worldwide, with limited long-term survival despite therapeutic advances. The increasing understanding of its molecular heterogeneity has paved the way for precision medicine approaches aiming to optimize treatment efficacy and reduce unnecessary toxicity.
No takes yet. Share an insight, caveat, or question.
Sullo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: